Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Mechanisms Evaluating Striatal Systems Imaging: LIFU Effects & Outcomes

NCT: NCT07710989 · NOT_YET_RECRUITING

NCT IDNCT07710989
StatusNOT_YET_RECRUITING
Start Date2027-02-01
Completion2027-12-01
SponsorUniversity of California, San Francisco (OTHER)
First posted
Last updated

Brief Summary

Individuals with schizophrenia often experience persistent auditory hallucinations despite treatment with antipsychotic medications. Research suggests that abnormal communication between the striatum and the auditory cortex contributes to hallucinations. This first-in-human, proof-of-concept Phase 1 study will evaluate the safety, feasibility, and preliminary effects of repeated-session low-intensity focused ultrasound (LIFU), a non-invasive neuromodulation technique targeting the striatum. The study will examine whether LIFU can safely modulate brain circuits involved in hallucinations, reduce abnormal communication between the striatum and auditory cortex, and improve auditory hallucination symptoms.

Frequently Asked Questions

What is Mechanisms Evaluating Striatal Systems Imaging: LIFU Effects & Outcomes?

Mechanisms Evaluating Striatal Systems Imaging: LIFU Effects & Outcomes is a clinical trial registered under NCT07710989. Current status: NOT_YET_RECRUITING.

What is the status of NCT07710989?

The current status of NCT07710989 (Mechanisms Evaluating Striatal Systems Imaging: LIFU Effects & Outcomes) is: NOT_YET_RECRUITING.

When did Mechanisms Evaluating Striatal Systems Imaging: LIFU Effects & Outcomes start?

Mechanisms Evaluating Striatal Systems Imaging: LIFU Effects & Outcomes started on 2027-02-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.